Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Forum Against Cancer Europe (FACE) : Cross Border Healthcare

Prof Paolo Casali - Istituto Nazionale Tumori, Milan, Italy
Forum Against Cancer Europe (FACE) : Cross Border Healthcare ( Prof Paolo Casali - Istituto Nazionale Tumori, Milan, Italy )
17 Nov 2010

Problems of implementing cross-border healthcare

Nessa Childers - Member of the European Parliament
Problems of implementing cross-border healthcare ( Nessa Childers - Member of the European Parliament )
17 Nov 2010

Prostate screening and the Forum Against Cancer Europe

Prof Louis Denis - Oncology Centre, Antwerp, Belgium
Prostate screening and the Forum Against Cancer Europe ( Prof Louis Denis - Oncology Centre, Antwerp, Belgium )
17 Nov 2010

Treatment of neuroendocrine tumours with everolimus

Dr Nicola Fazio - European Institute of Oncology, Milan, Italy
Treatment of neuroendocrine tumours with everolimus ( Dr Nicola Fazio - European Institute of Oncology, Milan, Italy )
10 Nov 2010

The development of PARP inhibitors a new drug to treat prostate cancer

Dr Johann de Bono - The Institute of Cancer Research & Royal Marsden Hospital, Surrey, UK
The development of PARP inhibitors a new drug to treat prostate cancer ( Dr Johann de Bono - The Institute of Cancer Research & Royal Marsden Hospital, Surrey, UK )
10 Nov 2010

How to select targeted therapy in renal cancer

Prof Bernard Escudier - Institut Gustave Roussy, Paris, France
How to select targeted therapy in renal cancer ( Prof Bernard Escudier - Institut Gustave Roussy, Paris, France )
10 Nov 2010

Cardiotoxicity and predictive biomarkers for metastatic colorectal cancer

Prof Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Cardiotoxicity and predictive biomarkers for metastatic colorectal cancer ( Prof Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
10 Nov 2010

Optimal treatment for colorectal cancer patients with liver metastases

Prof Peter Naredi - Umea University, Sweden
Optimal treatment for colorectal cancer patients with liver metastases ( Prof Peter Naredi - Umea University, Sweden )
10 Nov 2010

Bevacizumab as part of standard first line treatment of ovarian cancer

Prof Jonathan Ledermann - University College London, UK
Bevacizumab as part of standard first line treatment of ovarian cancer ( Prof Jonathan Ledermann - University College London, UK )
10 Nov 2010

Pain management and the treatment of cancer patients with low blood counts

Prof Dorothy Keefe - The University of Adelaide, Australia
Pain management and the treatment of cancer patients with low blood counts ( Prof Dorothy Keefe - The University of Adelaide, Australia )
10 Nov 2010

GOG-218: Bevacizumab plus standard chemo for ovarian cancer

Prof Rob Coleman - University of Texas M.D. Anderson Cancer Center, Houston, USA
GOG-218: Bevacizumab plus standard chemo for ovarian cancer ( Prof Rob Coleman - University of Texas M.D. Anderson Cancer Center, Houston, USA )
10 Nov 2010

Implementation of ESMO guidelines

Prof Andrés Cervantes - University of Valencia, Spain
Implementation of ESMO guidelines ( Prof Andrés Cervantes - University of Valencia, Spain )
10 Nov 2010